Melissa Rodriguez

发表

Real-Time Signaling Assays Demonstrate Somatostatin Agonist Bias for Ion Channel Regulation in Somatotroph Tumor Cells

J. Frost, A. Schonbrunn, Melissa Rodriguez, 2018, Journal of the Endocrine Society.

Tumor and Stem Cell Biology Haploinsufficiency in the Prometastasis Kiss 1 Receptor Gpr 54 Delays Breast Tumor Initiation , Progression , and Lung Metastasis

Dali Li, Jian Luo, Mingyao Liu, 2011 .

Phosphatidylinositol 5-phosphate 4-kinase

F. Tamanoi, K. Jacobson, Mark A Sussman, 2012 .

Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways

Mingyao Liu, Xiufeng Pang, Z. Yi, 2008, Molecular Cancer Therapeutics.

PCAF Lysine Acetyltransferase

F. Tamanoi, K. Jacobson, Mark A Sussman, 2008 .

Leucine-rich repeat–containing G protein–coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial–mesenchymal transition

Mingyao Liu, Weijia Luo, Melissa Rodriguez, 2017, The Journal of Biological Chemistry.

A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting

Sukhen C Ghosh, A. Schonbrunn, Melissa Rodriguez, 2017, The Journal of Nuclear Medicine.

Lgr4 is a key regulator of prostate development and prostate stem cell differentiation

Dali Li, Mingyao Liu, Weijia Luo, 2013, Stem cells.

Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells

J. Qi, J. Bradner, J. Sheng, 2014, Molecular Cancer Therapeutics.

Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis.

Mingyao Liu, Dali Li, Jian Luo, 2011, Cancer research.

Highly active combination of BRD 4 antagonist and histone deacetylase inhibitor against human acute myeloid leukemia ( AML ) cells

J. Qi, J. Bradner, J. Sheng, 2013 .

PTPe (RPTPe and Cyt-PTPe)

F. Tamanoi, K. Jacobson, Mark A Sussman, 2012 .

A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy.

K. Batra, B. Haley, A. Frankel, 2021, Clinical breast cancer.

Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting.

T. Reiner, S. Kossatz, Sukhen C Ghosh, 2017, ACS medicinal chemistry letters.

Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis.

Mingyao Liu, Dali Li, Jian Luo, 2011, Cancer research.

BRD4 Antagonist and Histone Deacetylase Inhibitor: A Novel Synergistic Combination Against Human Acute Myeloid Leukemia (AML) Cells

J. Qi, J. Bradner, K. Bhalla, 2013 .